Izotropic Corporation (OTCMKTS:IZOZF – Free Report) – Analysts at Zacks Research cut their FY2027 earnings per share estimates for shares of Izotropic in a note issued to investors on Tuesday, August 25th. Zacks Research analyst B. Sorensen now anticipates that the company will post earnings per share of $0.03 for the year, down from their prior estimate of $0.08. The consensus estimate for Izotropic’s current full-year earnings is $0.03 per share.
Izotropic Price Performance
Shares of IZOZF stock opened at $0.17 on Friday. Izotropic has a 52-week low of $0.12 and a 52-week high of $0.37. The business has a 50-day simple moving average of $0.18 and a 200-day simple moving average of $0.18.
About Izotropic
Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses. Izotropic Corporation was incorporated in 2016 and is headquartered in Surrey, Canada.
Featured Stories
- Five stocks we like better than Izotropic
- 3 Stocks Facing New Pressure From Section 338 Tariffs on Canadian Goods
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
Receive News & Ratings for Izotropic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Izotropic and related companies with MarketBeat.com's FREE daily email newsletter.
